Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D
Endpoints
Thu, 06/9/22 - 10:46 am
Pfizer
David Roblin
machine learning
funding
gemonics
R&D
Relation Therapeutics
Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org
Endpoints
Fri, 06/3/22 - 10:54 am
Boehringer Ingelheim
oncology
cancer
Singapore
R&D
Pfizer's new vaccine R&D leader Anderson has a high bar to reach in replacing Jansen
Fierce Pharma
Thu, 06/2/22 - 07:15 pm
Pfizer
R&D
vaccines
GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Astellas
immuno-oncology
R&D
Go Therapeutics
glycoprotein targets
GSK said to be close to finding partner for science cluster in UK
Pharmaforum
Mon, 05/30/22 - 10:16 am
GSK
UK
R&D
Another biotech that went public in pandemic boom aims to weather the bear market through R&D cutbacks
Endpoints
Thu, 05/19/22 - 10:54 am
Nanobiotix
R&D
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Endpoints
Wed, 05/18/22 - 10:32 am
Locus Biosciences
venture capital
funding
antibiotics
antibacterials
R&D
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
Agios to cut jobs as it moves away from exploratory research
BioPharma Dive
Mon, 05/16/22 - 07:31 pm
Agios Pharmaceuticals
layoffs
R&D
A week after disclosing layoffs, BridgeBio nets a $90M upfront cancer R&D pact with Bristol Myers
Endpoints
Thu, 05/12/22 - 10:24 am
BridgeBio
Bristol Myers Squibb
cancer
R&D
Against a historic market downturn, Moma Therapeutics raises $150M for precision cancer research
BioPharma Dive
Wed, 05/11/22 - 10:51 am
MOMA Therapeutics
funding
R&D
cancer
Novo Nordisk forges close ties with biotech VC Flagship
Pharmaforum
Wed, 05/11/22 - 10:39 am
Novo Nordisk
R&D
Flagship Pioneering
venture capital
Astellas, Twist Join Forces to Enhance Tumor Immunity
BioSpace
Tue, 05/10/22 - 10:38 pm
Astellas
Twist Bioscience
R&D
antibodies
tumor immunity
Covid drives a record jump in research spending for big pharma
EP Vantage
Mon, 05/9/22 - 11:24 pm
COVID-19
pandemic
R&D
Illumina and Deerfield Team Up to Utilize AI, Genomics in Drug Development
BioSpace
Fri, 05/6/22 - 10:48 am
Illumina
Deerfield
R&D
drug discovery
artificial intelligence
AstraZeneca plans new R&D hub in Kendall Square
Pharmaforum
Fri, 04/29/22 - 10:49 am
AstraZeneca
R&D
Cambridge MA
Kendall Square
earnings
A potential target for Alzheimer's treatment? Researchers unearth new immune response pathway
Endpoints
Mon, 04/18/22 - 11:53 pm
drug development
R&D
Alzheimer's disease
Boehringer Ingelheim boosts R&D commitment, promises up to 15 new product launches by 2025
Endpoints
Tue, 04/5/22 - 11:31 pm
Boehringer Ingelheim
R&D
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech
Tue, 04/5/22 - 11:13 am
Takeda
gene therapy
Evozyne
R&D
As biotech retreats, gene therapy companies retrench and redraw plans
BioPharma Dive
Thu, 03/24/22 - 08:29 pm
biotech
gene therapy
layoffs
R&D
Bluebird Bio
Allogene
uniQure
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »